{"schema_version":"secwatch.filing_event.v1","accession":"0001646972-26-000028","form_type":"8-K","ticker":"ACI","cik":"0001646972","company_name":"Albertsons Companies, Inc.","filed_at":"2026-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.656488+00:00","generated_at":"2026-05-15T06:23:53.351422+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"confidence":"high","headline":"Albertsons Q4 adj EPS $0.48 (+4% YoY); opioid charge $774M; dividend +13%; buyback to $2B","bullets":["Q4 adj net income $252M ($0.48) vs $269.5M ($0.46) prior year; adj EBITDA $903M.","Recorded $774M ($600M after-tax) opioid settlement charge; framework to pay $774M over 9 years.","FY2026 guidance: adj EPS $2.22-$2.32, adj EBITDA $3.85-$3.925B, identical sales 0.0-1.0%.","Quarterly dividend raised 13% to $0.17 (annualized $0.68); payable May 8 to April 24 record.","Share repurchase authorization increased by $900M to $2.0B remaining; completed $1.5B buyback in FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001646972-26-000028","json":"https://secwatch.observer/filing/0001646972-26-000028.json","markdown":"https://secwatch.observer/filing/0001646972-26-000028.md","text":"https://secwatch.observer/filing/0001646972-26-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1646972/000164697226000028/0001646972-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1646972/000164697226000028/aci-20260414.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:23:53.351422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}